Key facts
- Clemens Martin Auer, president of the European Health Forum Gastein, stated that Europe has an implementation problem with health policy.
- Auer called for greater cooperation between defense and health sectors to shore up pharmaceutical supply chains.
- The EU public health committee adopted a report on cancer, advocating for dedicated funding and action on prevention.
- MEPs voted in favor of a legislative initiative resolution to improve rare cancer diagnosis and treatment.
- A European Parliament event exploring the role of wine in health policy was held on World Heart Day.
The European Health Forum Gastein, a four-day conference, began on September 29, 2026, with calls from its president, Clemens Martin Auer, for increased action on health policy implementation. Auer expressed frustration with the slow pace of policy execution across Europe, which he believes hinders the bloc's ability to address challenges such as climate change, health security, AI, and workforce issues. He highlighted that while Europe possesses ideas and technical skills, the primary obstacle lies in effective implementation.
Auer also pointed to capricious U.S. health policies, including efforts to reduce domestic drug prices, as a source of global uncertainty that impacts investment decisions by drugmakers, potentially diverting investment towards China. He suggested that European health systems could be strengthened by a willingness to pay more for products like generics to secure supply chains.
Discussions at the conference are expected to heavily feature the pharmaceutical industry, with U.S. policies and European drug pricing serving as underlying themes in debates on health security, accessibility, and competitiveness. Auer referenced the Draghi report, which proposed measures to enhance competitiveness over two years ago, questioning the substantial implementation of its recommendations given worsening economic data.
Furthermore, Auer voiced concerns about the lack of action to protect health infrastructure, advocating for intelligence sharing and enhanced cooperation between defense and health sectors to bolster pharmaceutical supply chains and reduce reliance on external sources, especially in light of evolving warfare tactics like cyberattacks and drones.
Separately, lawmakers in the EU public health committee adopted a report on cancer, pushing for dedicated funding in the next multiannual financial framework, increased focus on prevention, and equitable access to cancer screening, diagnosis, and treatment across the EU. The report faced controversy over its wording on alcohol consumption, with the Association of European Cancer Leagues stating that referring to "levels exceeding scientifically established health recommendations" implies a safe threshold, which they deem misleading.
MEPs also voted in favor of a legislative initiative resolution to improve rare cancer diagnosis, ensure equal treatment access, and enhance patient care for rare diseases, which affect millions across Europe, disproportionately children. The committee's recommendations will be put to a vote at the next European Parliament plenary session.
